Vijay Kumar Ulaganathan

Vijay Kumar Ulaganathan

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 August 2012 in Nature
Verified
Journal Article
Closed access
FOFrancesca Odoardi
Francesca Odoardi
CSChristopher Sie
Christopher Sie
KSKristina Streyl
Kristina Streyl
VUVijay Kumar Ulaganathan
Vijay Kumar Ulaganathan
CSChristian Schläger
Christian Schläger
AFAlexander Flügel
Alexander Flügel

16 December 2015 in Nature
Verified
Journal Article
Closed access
VUVijay Kumar Ulaganathan
Vijay Kumar Ulaganathan
BSBianca Sperl
Bianca Sperl
URUlf R. Rapp
Ulf R. Rapp
AUAxel Ullrich
Axel Ullrich

2 June 2010 in Brain
Verified
Journal Article
Open access
PDF file
CCChiara Cordiglieri
Chiara Cordiglieri
FOFrancesca Odoardi
Francesca Odoardi
BZBo Zhang
Bo Zhang
MNMerle Nebel
Merle Nebel
NKNaoto Kawakami
Naoto Kawakami
AFAlexander Flügel
Alexander Flügel
Nicotinic acid adenine dinucleotide phosphate represents a newly identified second messenger in T cells involved in antigen receptor-mediated calcium signalling. Its function in vivo is, however, unknown due to the lack of biocompatible inhibitors. Using a recently developed inhibitor, we explored the role of nicotinic acid adenine dinucleotide phosphate in autoreactive effector T cells during experimental autoimmune encephalomyelitis, the animal model for multiple sclerosis. We provide in vitro and in vivo evidence that calcium signalling controlled by nicotinic acid adenine dinucleotide phosphate is relevant for the pathogenic potential of autoimmune effector T cells. Live two photon imaging and molecular analyses revealed that nicotinic acid adenine dinucleotide phosphate signalling regulates T cell motility and re-activation upon arrival in the nervous tissues. Treatment with the nicotinic acid adenine dinucleotide phosphate inhibitor significantly reduced both the number of stable arrests of effector T cells and their invasive capacity. The levels of pro-inflammatory cytokines interferon-gamma and interleukin-17 were strongly diminished. Consecutively, the clinical symptoms of experimental autoimmune encephalomyelitis were ameliorated. In vitro, antigen-triggered T cell proliferation and cytokine production were evenly suppressed. These inhibitory effects were reversible: after wash-out of the nicotinic acid adenine dinucleotide phosphate antagonist, the effector T cells fully regained their functions. The nicotinic acid derivative BZ194 induced this transient state of non-responsiveness specifically in post-activated effector T cells. Naïve and long-lived memory T cells, which express lower levels of the putative nicotinic acid adenine dinucleotide phosphate receptor, type 1 ryanodine receptor, were not targeted. T cell priming and recall responses in vivo were not reduced. These data indicate that the nicotinic acid adenine dinucleotide phosphate/calcium signalling pathway is essential for the recruitment and the activation of autoaggressive effector T cells within their target organ. Interference with this signalling pathway suppresses the formation of autoimmune inflammatory lesions and thus might qualify as a novel strategy for the treatment of T cell mediated autoimmune diseases.

1 January 2013 in Clinica Chimica Acta
Verified
Journal Article
Closed access
SLSimon Lytton
Simon Lytton
EAEmiliano Antiga
Emiliano Antiga
SPSascha Pfeiffer
Sascha Pfeiffer
TMTorsten Matthias
Torsten Matthias
ASAnna Szaflarska-Poplawska
Anna Szaflarska-Poplawska
MCMarzia Caproni
Marzia Caproni

3 April 2018 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
DKDaniel Kogan
Daniel Kogan
AGAlexander Grabner
Alexander Grabner
CYChristopher Yanucil
Christopher Yanucil
CFChristian Faul
Christian Faul
VUVijay Kumar Ulaganathan
Vijay Kumar Ulaganathan
Immune evasion and the suppression of antitumor responses during cancer progression are considered hallmarks of cancer and are typically attributed to tumor-derived factors. Although the molecular basis for the crosstalk between tumor and immune cells is an area of active investigation, whether host-specific germline variants can dictate immunosuppressive mechanisms has remained a challenge to address. A commonly occurring germline mutation (c.1162G>A/rs351855 G/A) in the FGFR4 (CD334) gene enhances signal transducer and activator of transcription 3 (STAT3) signaling and is associated with poor prognosis and accelerated progression of multiple cancer types. Here, using rs351855 SNP–knockin transgenic mice and Fgfr4-knockout mice, we reveal the genotype-specific gain of immunological function of suppressing the CD8/CD4+FOXP3+CD25+ regulatory T cell ratio in vivo. Furthermore, using knockin transgenic mouse models for lung and breast cancers, we establish the host-specific, tumor-extrinsic functions of STAT3-enhancing germline variants in impeding the tumor infiltration of CD8 T cells. Thus, STAT3-enhancing germline receptor variants contribute to immune evasion through their pleiotropic functions in immune cells.

13 August 2024 in Apoptosis
Verified
Journal Article
Open access
PDF file
MVMartina H. Vasileva
Martina H. Vasileva
ABAnette Bennemann
Anette Bennemann
KZKarolin Zachmann
Karolin Zachmann
MSMichael P. Schön
Michael P. Schön
JFJorge Frank
Jorge Frank
VUVijay Kumar Ulaganathan
Vijay Kumar Ulaganathan
Anastasis is a phenomenon observed in cancer cells, where cells that have initiated apoptosis are able to recover and survive. This molecular event is increasingly recognized as a potential contributor to cancer metastasis, facilitating the survival and migration of tumor cells. Nevertheless, the identification of a specific surface marker for detecting cancer cells in anastasis remained elusive. Here we report our observation that the cell surface expression of CD24 is preferentially enriched in a non-adherent FSClowSSChigh melanoma subpopulation, which is generally considered a non-viable population in cultivated melanoma cell lines. More than 90% of non-adherent FSClowSSChighCD24+ve metastatic melanoma cells exhibited bonafide features of apoptosis on the cell surface and in the nucleus, marking apoptotic or seemingly apoptotic subpopulations of the in vitro cultivated metastatic melanoma cell lines. Unexpectedly, however, the CD24+ve subpopulation, despite being apoptotic, showed evidence of metabolic activity and exhibited proliferative capacities, including anchorage-independent growth, when inoculated in soft agarose growth medium. These findings indicate that apoptotic FSClowSSChighCD24+ve melanoma subpopulations are capable of reversing the progression of apoptosis. We report CD24 as the first novel cell surface marker for anastasis in melanoma cells.